Mediclinic International plc
MEI
Rangering i aksjer
#4308
Mediclinic International plc is a prominent healthcare provider that, through... Mediclinic International plc is a prominent healthcare provider that, through its various subsidiaries, manages and operates private hospital facilities. Operating under its well-known Mediclinic and Hirslanden brands, the firm delivers a broad spectrum of specialized and comprehensive healthcare services. Its extensive global network spans Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. This network comprises 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, and 2 mental health facilities, which collectively feature 453 operating theatres and approximately 11,538 inpatient beds. Beyond direct patient care, Mediclinic also offers a range of auxiliary and support services, including treasury functions, medical equipment sourcing and procurement, emergency medical response, general management, food and catering, healthcare administration, and debt recovery. Furthermore, the company handles the management of its healthcare personnel and maintains its property portfolio. Its operations also extend to managing intellectual property and engaging in the medical supply and procurement sector. Established in 1983, the company's headquarters are located in Stellenbosch, South Africa.
Aksjekurs
$6.02
Sist synkronisert: 2023-05-26
Markedsverdi
$3.60B
Endring (1 dag)
-18.50%
Endring (1 år)
0.00%
Land
ZA
Handel Mediclinic International plc (MEI)
Kategori
Healthcare
Antall utestående aksjer for Mediclinic International plc (MEI)
Antall utestående aksjer per October 2026: 0
Ifølge Mediclinic International plc sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av October 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Mediclinic International plc (MEI) fra 2002 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2022 | 737.24M | 0.00% |
| 2021 | 737.24M | 0.00% |
| 2020 | 737.21M | 0.00% |
| 2019 | 737.19M | 0.01% |
| 2018 | 737.11M | 0.02% |
| 2017 | 736.94M | 23.14% |
| 2016 | 598.44M | -29.04% |
| 2015 | 843.39M | 4.21% |
| 2014 | 809.32M | 9.09% |
| 2013 | 741.86M | 18.27% |
| 2012 | 627.28M | 4.12% |
| 2011 | 602.47M | 7.27% |
| 2010 | 561.65M | 0.41% |
| 2009 | 559.34M | 32.72% |
| 2008 | 421.44M | 17.85% |
| 2007 | 357.61M | 3.01% |
| 2006 | 347.14M | 1.39% |
| 2005 | 342.37M | 0.45% |
| 2004 | 340.84M | -0.23% |
| 2003 | 341.63M | -2.05% |
| 2002 | 348.76M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 222.83M | - |
US
|
|
| - | - |
DE
|
|
| 83.52M | - |
US
|
|
| 350.00M | - |
SA
|
|
| 2.18B | - |
BR
|
